Option Care Health, Inc. (OPCH) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Option Care Health, Inc. (OPCH) Healthcare & Pipeline Overview

Option Care Health, Inc. delivers home and alternate site infusion services across the U.S., providing therapies for chronic and acute conditions. With a focus on patient-centered care and a network of infusion centers, Option Care Health addresses the growing demand for accessible and cost-effective healthcare solutions, positioning itself in a competitive healthcare landscape.

What Is the Investment Thesis for OPCH?

Option Care Health presents a notable research candidate due to its strong market position in the growing home infusion services industry. With a P/E ratio of 10.0 and a profit margin of 3.6%, the company demonstrates solid financial performance. Key growth catalysts include the increasing demand for home-based healthcare services and the expansion of the company's service offerings. The company's established network of infusion centers and focus on patient care provide a competitive advantage. However, potential risks include regulatory changes and competition from other healthcare providers. Investors should monitor the company's ability to maintain its market share and manage costs effectively.

Based on FMP financials and quantitative analysis

OPCH Key Highlights

Market Cap of $3.52B reflects substantial investor confidence in Option Care Health's market position and growth potential.

• P/E Ratio of 10.0 indicates a reasonable valuation relative to earnings, suggesting potential for further appreciation.
• Gross Margin of 18.0% demonstrates the company's ability to manage costs effectively in the competitive healthcare services market.
• Profit Margin of 3.6% shows the efficiency of Option Care Health in converting revenue into profit.
• Beta of 0.95 suggests that the stock is slightly less volatile than the overall market, potentially offering a more stable investment.

Who Are OPCH's Competitors?

OPCH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are OPCH's Key Strengths?

Comprehensive range of infusion therapies and services.

• Established network of infusion centers and healthcare professionals.
• Strong relationships with healthcare providers and payers.
• Commitment to high-quality, patient-centered care.

What Are OPCH's Weaknesses?

Reliance on reimbursement from payers.

• Exposure to regulatory changes and healthcare policy reforms.
• Competition from other home infusion providers and specialty pharmacies.
• Potential for service disruptions due to supply chain issues or natural disasters.

What Could Drive OPCH Stock Higher?

Expansion of service offerings to include additional therapies and services.

• Geographic expansion into underserved markets.
• Strategic partnerships with hospitals and physician groups.
• Leveraging technological advancements to improve efficiency and patient care.

What Are the Key Risks for OPCH?

Increasing competition from other home infusion providers.

• Changes in reimbursement rates or healthcare policies.
• Product liability claims or recalls.
• Economic downturn or recession.
• Reliance on reimbursement from payers.

What Are the Growth Opportunities for OPCH?

• Expansion of Service Offerings: Option Care Health has the opportunity to expand its service offerings to include additional therapies and services, such as specialty pharmacy services and chronic disease management programs. This expansion would allow the company to attract new patients and increase revenue from existing patients. The market for specialty pharmacy services is estimated to be worth billions of dollars, providing a significant growth opportunity for Option Care Health. Timeline: Ongoing.
• Geographic Expansion: Option Care Health can expand its geographic reach by opening new infusion centers in underserved markets and acquiring smaller home infusion providers. This expansion would allow the company to reach more patients and increase its market share. The market for home infusion services is growing rapidly, particularly in rural areas where access to healthcare is limited. Timeline: Ongoing.
• Strategic Partnerships: Option Care Health can form strategic partnerships with hospitals, physician groups, and other healthcare providers to expand its referral network and gain access to new patients. These partnerships would allow the company to integrate its services into the broader healthcare ecosystem and improve patient outcomes. Many hospitals are looking to partner with home infusion providers to reduce costs and improve patient satisfaction. Timeline: Ongoing.
• Technological Advancements: Option Care Health can leverage technological advancements, such as telehealth and remote monitoring, to improve the efficiency and effectiveness of its services. These technologies would allow the company to provide more convenient and personalized care to patients. The market for telehealth and remote monitoring is growing rapidly, driven by the increasing adoption of digital health technologies. Timeline: Ongoing.
• Value-Based Care: Option Care Health can participate in value-based care arrangements with payers, such as Medicare and Medicaid, to demonstrate the value of its services and improve patient outcomes. These arrangements would incentivize the company to provide high-quality, cost-effective care. The shift towards value-based care is accelerating, creating new opportunities for companies like Option Care Health to demonstrate their value. Timeline: Ongoing.

What Are OPCH's Competitive Advantages?

• Established Network: Option Care Health has an established network of infusion centers and healthcare professionals, providing a competitive advantage in terms of geographic reach and service delivery.
• Comprehensive Service Offerings: The company offers a comprehensive suite of infusion therapies and related services, allowing it to meet the diverse needs of patients and healthcare providers.
• Focus on Patient Care: Option Care Health is committed to providing high-quality, patient-centered care, which helps to build trust and loyalty with patients and referral sources.
• Strong Relationships: Option Care Health has strong relationships with healthcare providers and payers, which helps to ensure a steady stream of referrals and reimbursement for services.

What Does OPCH Do?

Option Care Health, Inc. was formed to address the increasing need for accessible and cost-effective infusion therapy outside of traditional hospital settings. The company provides a comprehensive suite of infusion services, including anti-infective therapies, home parenteral and enteral nutrition, immunoglobulin infusion therapies, and treatments for chronic inflammatory and neurological disorders. These services are delivered either in patients' homes or at the company's network of infusion centers. Since its inception, Option Care Health has focused on expanding its geographic reach and service offerings to meet the diverse needs of patients across the United States. The company has grown through strategic acquisitions and organic growth, enhancing its capabilities and market presence. Option Care Health's commitment to patient care is reflected in its team of healthcare professionals, including nurses, pharmacists, and other specialists, who work closely with patients and their healthcare providers to ensure optimal outcomes. Option Care Health operates in a competitive market, facing competition from other home infusion providers, specialty pharmacies, and hospitals. The company differentiates itself through its comprehensive service offerings, focus on patient care, and established network of infusion centers. Option Care Health continues to invest in technology and infrastructure to improve efficiency and enhance the patient experience.

What Products and Services Does OPCH Offer?

• Provides anti-infective therapies for patients at home.
• Offers home infusion services to treat heart failure.
• Delivers home parenteral and enteral nutrition support.
• Administers immunoglobulin infusion therapies for immune deficiencies.
• Treats chronic inflammatory disorders like Crohn's disease and rheumatoid arthritis.
• Manages neurological disorders such as ALS and muscular dystrophy with infusion therapies.
• Provides infusion therapies for bleeding disorders.
• Offers specialized therapies for high-risk pregnancies.

How Does OPCH Make Money?

• Provides infusion therapies and related services directly to patients in their homes or at alternate sites.
• Contracts with healthcare providers and payers to receive referrals and reimbursement for services.
• Generates revenue through a combination of fee-for-service and value-based care arrangements.
• Manages a network of infusion centers and healthcare professionals to deliver high-quality care.

What Industry Does OPCH Operate In?

Option Care Health operates within the medical care facilities industry, which is experiencing growth due to the increasing demand for home-based healthcare services. The aging population and the rising prevalence of chronic diseases are driving the need for more accessible and cost-effective healthcare solutions. The industry is competitive, with several players offering similar services. Option Care Health differentiates itself through its comprehensive service offerings, focus on patient care, and established network of infusion centers. The market is expected to continue to grow, driven by technological advancements and changing patient preferences.

Who Are OPCH's Key Customers?

• Patients with acute and chronic conditions requiring infusion therapy.
• Hospitals and physician groups referring patients for home infusion services.
• Payers, including insurance companies and government healthcare programs, reimbursing for services.
• Managed care organizations seeking cost-effective and high-quality infusion therapy solutions.

Wall Street analysts project Option Care Health, Inc. revenue of about $5.75B for fiscal 2026, with EPS near $1.88. The estimate reflects 10 contributing analysts.

Option Care Health, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.55 places it in the safe zone, indicating low near-term bankruptcy risk.

Return on equity for Option Care Health, Inc. stands at 15.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.1%, showing how much profit it generates from its asset base. OPCH trades at a trailing price-to-earnings ratio of 9.99, below the Healthcare sector average of ~23x. Its free cash flow yield is 7.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.64 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.3%, the inverse of the P/E and a quick read on earnings relative to price.

Option Care Health, Inc. (OPCH) Valuation Context

Valued at $3.52B, OPCH is classified as a mid-cap stock. Relative to its peer group, OPCH's quantitative score of 78/100 is roughly in line with the peer average of 73/100.

Company Profile

Option Care Health, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Bannockburn, US. The company is led by CEO John C. Rademacher. OPCH has traded publicly since 1996.

OPCH Financials

OPCH Latest News

OPCH Analyst Consensus

OPCH MoonshotScore

OPCH Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources